TD Cowen Issues Positive Forecast for American Well (NYSE:AMWL) Stock Price

Key Points

• TD Cowen raised its price target on American Well from $5.00 to $8.00 but kept a "hold" rating, implying roughly a 7.9% upside from the current share price.
• Amwell's Q1 results beat expectations with $54.9M revenue and EPS of ($0.66), while Q2 and FY2026 revenue guidance came in essentially in line with Street expectations, reducing surprise risk.
• The consensus among analysts is a Hold with an average target of $7.58; the stock traded around $7.42 midday, insiders have recently sold shares, and institutional investors own about 56% of shares.

American Well (NYSE:AMWL - Get Free Report) had its target price increased by research analysts at TD Cowen from $5.00 to $8.00 in a report issued on Wednesday,Benzinga reports. The brokerage currently has a "hold" rating on the stock. TD Cowen's price target would indicate a potential upside of 7.89% from the company's current price.

Other equities analysts also recently issued reports about the stock. Weiss Ratings reiterated a "sell (e+)" rating on shares of American Well in a research note on Wednesday, January 21st. Wall Street Zen upgraded American Well from a "sell" rating to a "hold" rating in a research note on Sunday, March 22nd. Morgan Stanley boosted their target price on shares of American Well from $6.00 to $6.50 and gave the stock an "equal weight" rating in a report on Wednesday. Finally, Stifel Nicolaus cut their price objective on shares of American Well from $6.00 to $5.00 and set a "hold" rating on the stock in a research report on Friday, February 13th. One analyst has rated the stock with a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Hold" and an average target price of $7.58.

American Well Stock Performance

AMWL stock traded up $1.06 during midday trading on Wednesday, reaching $7.42. 161,781 shares of the company traded hands, compared to its average volume of 84,022. The firm has a market capitalization of $122.72 million, a price-to-earnings ratio of -1.25 and a beta of 1.52. The business has a 50 day moving average of $5.69 and a 200-day moving average of $5.03. American Well has a 52-week low of $3.71 and a 52-week high of $9.15.

American Well (NYSE:AMWL - Get Free Report) last issued its earnings results on Tuesday, May 5th. The company reported ($0.66) earnings per share for the quarter, topping the consensus estimate of ($0.77) by $0.11. The business had revenue of $54.88 million during the quarter, compared to analysts' expectations of $51.54 million. American Well had a negative return on equity of 35.33% and a negative net margin of 38.38%. Research analysts anticipate that American Well will post -2.88 earnings per share for the current year.

Insider Activity at American Well

In other news, insider Dmitry Zamansky sold 5,575 shares of the stock in a transaction on Wednesday, April 1st. The shares were sold at an average price of $5.30, for a total value of $29,547.50. Following the sale, the insider owned 241,080 shares in the company, valued at $1,277,724. This represents a 2.26% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Over the last quarter, insiders have sold 9,664 shares of company stock valued at $51,219. 12.80% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On American Well

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Hsbc Holdings PLC grew its holdings in American Well by 186.6% during the fourth quarter. Hsbc Holdings PLC now owns 46,565 shares of the company's stock worth $224,000 after acquiring an additional 30,316 shares during the period. NewEdge Advisors LLC acquired a new position in American Well in the fourth quarter valued at approximately $82,000. XTX Topco Ltd purchased a new stake in American Well in the 4th quarter worth approximately $215,000. Occudo Quantitative Strategies LP acquired a new stake in shares of American Well during the 4th quarter worth approximately $74,000. Finally, Squarepoint Ops LLC lifted its stake in shares of American Well by 74.5% in the 4th quarter. Squarepoint Ops LLC now owns 115,061 shares of the company's stock valued at $565,000 after purchasing an additional 49,135 shares during the period. 56.05% of the stock is owned by institutional investors and hedge funds.

American Well News Roundup

Here are the key news stories impacting American Well this week:

• Positive Sentiment: Q1 results: AMWL reported revenue of $54.9M (above the $51.5M consensus) and an EPS figure that topped some estimates (company reported ($0.66) vs. consensus around ($0.77)), signaling better-than-expected top-line performance and an EPS surprise. Amwell Q1 Press Release
• Neutral Sentiment: Revenue guidance: AMWL updated Q2 revenue guidance to $48M–$52M (consensus ~ $50.1M) and FY 2026 revenue guidance to $195M–$205M (consensus ~ $199.5M). Midpoints are essentially in line with Street expectations — reduces surprise risk but doesn’t materially change the growth outlook. GlobeNewswire: Q1 Results & Guidance
• Neutral Sentiment: Earnings call/transcript: Management commentary from the Q1 2026 earnings call may provide color on bookings, margin trajectory and product adoption — useful for gauging whether upside in revenue is sustainable. Seeking Alpha: Q1 2026 Call Transcript
• Negative Sentiment: Analyst positioning: Morgan Stanley raised its price target modestly from $6.00 to $6.50 but kept an "equal weight" rating — the new PT still implies downside versus the current share price, which may cap upside from analyst sentiment. TickerReport: Morgan Stanley PT Update

About American Well

American Well, operating under the trade name Amwell, is a Boston-based digital health company that develops and delivers telehealth solutions to healthcare providers, payers, employers and patients. Through its cloud-based platform, the company enables secure virtual visits, remote patient monitoring and integrated care coordination across a range of medical disciplines, including primary care, behavioral health, chronic disease management and urgent care.

The company's core offering, the Amwell Telehealth Platform, facilitates live video consultations, asynchronous messaging, e-prescribing and electronic health record integration.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.